Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

How important is HER2/neu amplification and expression when selecting patients for HER2/neu-targeted therapies?

Davol PA, Lum LG.

Clin Breast Cancer. 2004 Apr;5(1):70-1. No abstract available.

PMID:
15140288
2.

HER2 testing: a review of detection methodologies and their clinical performance.

Laudadio J, Quigley DI, Tubbs R, Wolff DJ.

Expert Rev Mol Diagn. 2007 Jan;7(1):53-64. Review.

PMID:
17187484
4.

Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.

Carney WP, Neumann R, Lipton A, Leitzel K, Ali S, Price CP.

Clin Breast Cancer. 2004 Jun;5(2):105-16. Review.

PMID:
15245613
5.

[Oncogene her-2/neu and ovarian carcinoma: intraperitoneal cellular immunotherapy].

Prevot S.

Ann Pathol. 2000;20 Suppl:S92-3. Review. French. No abstract available.

PMID:
11261311

Supplemental Content

Write to the Help Desk